Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Neuroimaging Clinics of North America
|
April 11, 2017
Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants
Iris Dekker, Mike P Wattjes
Patient Education and Counseling
|
May 15, 2025
"What if you were the patient?" A mixed methods study on improving hospital workers' awareness of the patient experience through virtual reality
Hafize Demirci, Noureddine Achbab, Judith Weeda, et al.
Neuroimage. Clinical
|
April 25, 2025
Regional cerebellar atrophy related to disability and cognitive progression in multiple sclerosis
Myrte Strik, Iris Dekker, Aurélie Ruet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 7, 2017
Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
Iris Dekker, Madeleine H Sombekke, Birgit I Witte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 22, 2017
Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
Cyra E Leurs, Zoé LE van Kempen, Iris Dekker, et al.
Journal of Neurology
|
June 22, 2020
Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance
Nina L van Faals, Iris Dekker, Lisanne J Balk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 3, 2019
Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
Iris Dekker, Madeleine H Sombekke, Lisanne J Balk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 30, 2022
Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
Myrte Strik, Anand Jc Eijlers, Iris Dekker, et al.
Neurology
|
September 26, 2019
The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms
Zoé L E van Kempen, Djoeke Doesburg, Iris Dekker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 26, 2020
Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis
Myrte Strik, Declan T Chard, Iris Dekker, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Neuroimaging Clinics of North America
|
April 11, 2017
Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants
Iris Dekker, Mike P Wattjes
Patient Education and Counseling
|
May 15, 2025
"What if you were the patient?" A mixed methods study on improving hospital workers' awareness of the patient experience through virtual reality
Hafize Demirci, Noureddine Achbab, Judith Weeda, et al.
Neuroimage. Clinical
|
April 25, 2025
Regional cerebellar atrophy related to disability and cognitive progression in multiple sclerosis
Myrte Strik, Iris Dekker, Aurélie Ruet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 7, 2017
Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
Iris Dekker, Madeleine H Sombekke, Birgit I Witte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 22, 2017
Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
Cyra E Leurs, Zoé LE van Kempen, Iris Dekker, et al.
Journal of Neurology
|
June 22, 2020
Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance
Nina L van Faals, Iris Dekker, Lisanne J Balk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 3, 2019
Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
Iris Dekker, Madeleine H Sombekke, Lisanne J Balk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 30, 2022
Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
Myrte Strik, Anand Jc Eijlers, Iris Dekker, et al.
Neurology
|
September 26, 2019
The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms
Zoé L E van Kempen, Djoeke Doesburg, Iris Dekker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 26, 2020
Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis
Myrte Strik, Declan T Chard, Iris Dekker, et al.
Page
of 2